Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Eiger BioPharmaceuticals Announces Positive Results of Investigator Sponsored Randomized Controlled Trial at University of Toronto with Peginterferon Lambda in Outpatients with Mild to Moderate COVID-

prnewswireOctober 16, 2020

Tag: Eiger BioPharmaceuticals , COVID-19 , Peginterferon Lambda

PharmaSources Customer Service